Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.

Source:http://linkedlifedata.com/resource/pubmed/id/19349549

J. Clin. Oncol. 2009 Jun 1 27 16 2638-44

Download in:

View as

General Info

PMID
19349549